Epacadostat

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameEpacadostat
Drug Alias NameEpacadostatum依多司他艾卡哚司他INCB-24360INCB-024360 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitors
TargetsIndoleamine 2,3-dioxygenase
Therapy Area/IndicationsUveal melanomaEsophageal adenocarcinomaSkin Melanoma +[47] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[36] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesIncyte Corp
China Registration ClassN/A

Develop Information

Active CompaniesWashington University School Of MedicineIncyte CorpNational Cancer Institute +[4] 
Inactive CompaniesAddario Lung Cancer Medical InstituteGeorgetown UniversityThe University Of California Davis +[11] 
Active IndicationsSolid tumoursProstatic Neoplasms, Castration-ResistantProstatic Neoplasms +[16] 
Inactive IndicationsUveal melanomaEsophageal adenocarcinomaSkin Melanoma +[31] 

Other Information

ATC CodeL01XX58
Related LinksN/A